These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24635692)

  • 1. Lessons learned from our elders: how to study polypharmacy in populations with intellectual and developmental disabilities.
    Stortz JN; Lake JK; Cobigo V; Ouellette-Kuntz HM; Lunsky Y
    Intellect Dev Disabil; 2014 Feb; 52(1):60-77. PubMed ID: 24635692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic medications use and side effects of individuals with intellectual and developmental disabilities.
    Charlot LR; Doerfler LA; McLaren JL
    J Intellect Disabil Res; 2020 Nov; 64(11):852-863. PubMed ID: 32959471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of medication reviews in identifying and reducing medication-related problems among people with intellectual disabilities: A systematic review.
    Nabhanizadeh A; Oppewal A; Boot FH; Maes-Festen D
    J Appl Res Intellect Disabil; 2019 Jul; 32(4):750-761. PubMed ID: 30793852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic Use Among Youths With Intellectual and Developmental Disabilities.
    McLaren JL; Lichtenstein JD; Metcalfe JD; Charlot LR; Drake RE; Beasley JB
    Psychiatr Serv; 2021 Sep; 72(9):988-997. PubMed ID: 33882691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pursuit of the magic pill: the overuse of psychotropic medications in children with intellectual and developmental disabilities in the USA.
    McLaren JL; Lichtenstein JD
    Epidemiol Psychiatr Sci; 2019 Aug; 28(4):365-368. PubMed ID: 30353794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective cohort study of prescription drug use among youth with intellectual/developmental disabilities in British Columbia.
    Marquis S; Marquis NE; Lunsky Y; McGrail KM; Baumbusch J
    J Intellect Disabil Res; 2024 Oct; 68(10):1156-1166. PubMed ID: 38773818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems.
    Scheifes A; Egberts TC; Stolker JJ; Nijman HL; Heerdink ER
    J Appl Res Intellect Disabil; 2016 Jul; 29(4):346-55. PubMed ID: 25882186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability.
    Haider SI; Ansari Z; Vaughan L; Matters H; Emerson E
    Res Dev Disabil; 2014 Nov; 35(11):3071-80. PubMed ID: 25129201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Medication Events Related to Hospitalization in the United States: A Comparison Between Adults With Intellectual and Developmental Disabilities and Those Without.
    Erickson SR; Kamdar N; Wu CH
    Am J Intellect Dev Disabil; 2020 Jan; 125(1):37-48. PubMed ID: 31877264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using administrative health data to identify individuals with intellectual and developmental disabilities: a comparison of algorithms.
    Lin E; Balogh R; Cobigo V; Ouellette-Kuntz H; Wilton AS; Lunsky Y
    J Intellect Disabil Res; 2013 May; 57(5):462-77. PubMed ID: 23116328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of educational modules for MRTs to better support patients with intellectual and developmental disabilities undergoing imaging procedures: A collaborative patient-oriented initiative.
    Jiwa MI; Armstrong S; Shao Y; Lunsky Y
    J Med Imaging Radiat Sci; 2020 Dec; 51(4S):S26-S30. PubMed ID: 32943363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demystifying moderators and mediators in intellectual and developmental disabilities research: a primer and review of the literature.
    Farmer C
    J Intellect Disabil Res; 2012 Dec; 56(12):1148-60. PubMed ID: 22283834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Needles in the haystack: Using open-text fields to identify persons with intellectual and developmental disabilities in administrative home care data.
    McKenzie K; Martin L; Ouellette-Kuntz H
    Res Dev Disabil; 2017 Oct; 69():85-95. PubMed ID: 28841496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of everyday choice and support-related choice for 8,892 randomly sampled adults with intellectual and developmental disabilities in 19 states.
    Tichá R; Lakin KC; Larson SA; Stancliffe RJ; Taub S; Engler J; Bershadsky J; Moseley C
    Intellect Dev Disabil; 2012 Dec; 50(6):486-504. PubMed ID: 23256691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designs and analyses of psychotropic and behavioral interventions for the treatment of problem behavior among people with intellectual and developmental disabilities.
    Courtemanche AB; Schroeder SR; Sheldon JB
    Am J Intellect Dev Disabil; 2011 Jul; 116(4):315-28. PubMed ID: 21740259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric Presentations and Medication Use in Older Adults With Intellectual and Developmental Disabilities.
    Wise E; Holingue C; Klein A; Caoili A; Charlot L; Barnhill J; Beasley JB
    Am J Geriatr Psychiatry; 2022 Jan; 30(1):65-77. PubMed ID: 34210596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of community rehabilitation providers in employment for persons with intellectual and developmental disabilities: results of the 2010-2011 National Survey.
    Domin D; Butterworth J
    Intellect Dev Disabil; 2013 Aug; 51(4):215-25. PubMed ID: 23909583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The state of the science of employment and economic self-sufficiency for people with intellectual and developmental disabilities.
    Nord D; Luecking R; Mank D; Kiernan W; Wray C
    Intellect Dev Disabil; 2013 Oct; 51(5):376-84. PubMed ID: 24303824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross-sectional total population study.
    McMahon M; Hatton C; Bowring DL
    J Intellect Disabil Res; 2020 Nov; 64(11):834-851. PubMed ID: 32902029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities and polypharmacy.
    von Lueder TG; Atar D
    Heart Fail Clin; 2014 Apr; 10(2):367-72. PubMed ID: 24656112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.